Title | Midlife Cardiovascular Health and Robust Versus Frail Late-Life Status: The Atherosclerosis Risk in Communities Study. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Palta P, Griswold M, Ranadive R, Bandeen-Roche K, Folsom AR, Petruski-Ivleva N, Burgard S, Kucharska-Newton A, B Windham G |
Journal | J Gerontol A Biol Sci Med Sci |
Volume | 77 |
Issue | 6 |
Pagination | 1222-1229 |
Date Published | 2022 06 01 |
ISSN | 1758-535X |
Keywords | Aged, Atherosclerosis, Blood Pressure, Body Mass Index, Cardiovascular Diseases, Cardiovascular System, Female, Frail Elderly, Frailty, Health Status, Humans, Male, Risk Factors, United States |
Abstract | BACKGROUND: We examined the relationship of midlife cardiovascular health (CVH) with late-life robustness among men and women and the impact of survivorship bias on sex differences in robustness. METHODS: Prospective analysis of 15 744 participants aged 45-64 (visit 1 median age: 54 years, 55% female, 27% Black) in 1987-1989 from the population-based Atherosclerosis Risk in Communities Study. CVH was operationalized according to the Life's Simple 7 (LS7) metric of health behaviors (smoking, weight, physical activity, diet, cholesterol, blood pressure, and glucose); each behavior was scored as ideal (2 points), intermediate (1 point), or poor (0 points) and summed. Late-life robust/prefrail/frailty was defined at visit 5 (2011-2013). Multinomial regression estimated relative prevalence ratios (RPRs) of late-life robustness/prefrailty/frailty/death across overall midlife LS7 score and components, for the full visit 1 sample. Separate analyses considered visit 5 survivors-only. RESULTS: For each 1-unit greater midlife LS7 score, participants had a 37% higher relative prevalence of being robust versus frail (overall RPR = 1.37 [95% confidence interval {CI}: 1.30-1.44]; women = 1.45 [1.36-1.54]; men = 1.24 [1.13-1.36]). Among the full visit 1 sample, women had a similar 1-level higher robustness category prevalence (RPR = 1.35 [95% CI: 1.32-1.39]) than men (RPR = 1.31 [95% CI: 1.27-1.35]) for every 1-unit higher midlife LS7 score. Among survivors, men were more likely to be robust than women at lower LS7 levels; differences were attenuated and not statistically different at higher midlife LS7 levels. CONCLUSIONS: Midlife CVH is positively associated with robustness in late life among men and women. Accounting for mortality in part explains documented sex differences in robustness across all levels of LS7. |
DOI | 10.1093/gerona/glab310 |
Alternate Journal | J Gerontol A Biol Sci Med Sci |
PubMed ID | 34661638 |
PubMed Central ID | PMC9159655 |
Grant List | U01 HL096812 / HL / NHLBI NIH HHS / United States R00 AG052830 / AG / NIA NIH HHS / United States HHSN268201700001I / HH / HHS / United States HHSN268201700002I / HL / NHLBI NIH HHS / United States HHSN268201700005I / HL / NHLBI NIH HHS / United States HHSN268201700003I / HL / NHLBI NIH HHS / United States / NH / NIH HHS / United States P30AG021334 / AG / NIA NIH HHS / United States P30 AG021334 / AG / NIA NIH HHS / United States HHSN268201700004I / HL / NHLBI NIH HHS / United States |